How much does bedaquiline (Snaery) cost approximately for 6 months?
When considering the treatment cost of Bedaquiline (Bedaquiline), it is necessary to comprehensively consider the domestic and foreign market conditions as well as the price of the drug and the reimbursement status of medical insurance.
In the domestic market, Bedaquiline (Sneril) has been launched and is covered by medical insurance, which allows patients to obtain subsidies or reimbursement to a certain extent. According to the information provided, the price of Bedaquiline (Sneril) with the specifications of 100mg*24 tablets is about four to five thousand yuan. This price is relatively high and may still be a burden for some patients.

In foreign markets, especially Russia, the original drug Bedaquiline (Sneril) is also available . Compared with domestic ones, the Russian version of the original drug is cheaper. Taking the specification of 100mg*188 tablets as an example, the price is about more than 10,000 yuan. This price is much cheaper than in the domestic market, which may have attracted some patients who need to take Bedaquiline (Sneril) for a long time to choose to purchase it from abroad.
However, it should be noted that even in foreign markets, the price of original drugs is still high for some patients. For patients who take long-term treatment with bedaquiline (Snaeryx), the cost of the drug may become a significant financial burden. Therefore, finding more affordable sources of medications and options covered by health insurance may be critical for patients.
In addition, although domestic and foreign Bedaquiline (Sneril) drugs are original drugs, there may be slight differences in specific therapeutic effects and side effects, and patients should carefully consider them when choosing to purchase them.
In general, Bedaquiline (Snaery) treatment costs are a significant expense in domestic and foreign markets. Patients should make a rational choice between domestic and foreign drug prices, medical insurance policies and other factors based on their actual situation and financial ability.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)